Cancer Patient Confined in the Bed Clinical Trial
— OSTEOOfficial title:
Osteopathy Treatment for Cancer Pain Related to the Confinement to Bed Pilot Study
Verified date | July 2022 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Staying confined in the bed is frequent at the end of life. The cancer patients can also experiment this situation, and consequences are painful, with pain increasing with the time. This pain are related to the joints stiffing , muscles mass decreasing, and tendons retractions . The non pharmacological approach associated with the conventional treatments can be interesting to assess in this frails patients.
Status | Completed |
Enrollment | 22 |
Est. completion date | February 2, 2020 |
Est. primary completion date | February 2, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Man or woman - Aged 18 years or older - Having signed informed consent to participate in the study - Patient affiliated to a social security scheme - Patient with pain affecting the musculoskeletal system following prolonged bed rest - Capable to understand French - Capable of completing self-assessment scales Exclusion Criteria: - Patients with bone metastases at risk for the use of osteopathy - Patients under legal protection measures - Patients with cognitive impairment preventing self-evaluation - Patient who is considered too fragile or with a clinical condition too unstable by the doctor refer to be included in the study - Patients in the pre-agonic or agonic phase |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Lyon Sud | Pierre-Bénite |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Decreased pain intensity of 2 points measured by Analog Visual Scale (AVS) before and after the session | 15 days | ||
Secondary | Decrease in analgesic consumption for pain related to immobilization | 15 days | ||
Secondary | Decreased 2 points of intensity of other symptoms associated before and after session measured with Edmonton Symptom Assessment System (ESAS). | 15 days |